Digital Content 
NEWS #PharmaBuzz
18 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251118317254/en/Veradermics-Advances-VDPHL01-in-Phase-23-Clinical-Trial-for-Female-Pattern-Hair-Loss-Marking-a-Milestone-in-the-Development-of-the-Potential-First-Ever-Oral-Prescription-Treatment-for-Women
14 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/samson-clinical-announces-completion-of-patient-enrolment-into-pivotal-phase-iii-clinical-trial-program-for-sublingual-minoxidil-in-male-pattern-baldness-302615355.html
16 Oct 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251016863981/en/Veradermics-Announces-Oversubscribed-%24150-Million-Series-C-Financing-to-Advance-VDPHL01-Through-Multiple-Phase-3-Trials-as-Potentially-the-First-Non-Hormonal-Oral-Therapeutic-for-Hair-Regrowth-in-Women-and-Men
07 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/first-patient-randomised-in-samson-clinical-phase-iii-sublingual-minoxidil-trial-for-male-pattern-hair-loss-androgenetic-alopecia-302523124.html
09 Jul 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eirion-therapeutics-to-present-at-the-2025-american-academy-of-dermatology-innovation-academy-meeting-302492376.html
30 Jun 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217998
Share 